📰 Cognitive Function News
Page 21 - Cognitive Function News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cognitive Function. Real-time updates on events, politics, business and more.
July 13, 2023
Intermittent fasting and keto are two big components of today's diet culture. Some people are combining them, but is that a good idea 2023?
July 12, 2023
Researchers at the University of Glasgow found that, of a sample of 103 young offenders, 82 had sustained a significant head injury at some point.
July 12, 2023
Researchers at the University of Glasgow found that, of a sample of 103 young offenders, 82 had sustained a significant head injury at some point.
July 12, 2023
Researchers at the University of Glasgow found that, of a sample of 103 young offenders, 82 had sustained a significant head injury at some point.
July 12, 2023
Researchers at the University of Glasgow found that, of a sample of 103 young offenders, 82 had sustained a significant head injury at some point.
July 11, 2023
/PRNewswire/ -- Eisai Co. Ltd (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that the company will present the latest findings on its...
July 10, 2023
Today we can announce the finalists for the NutraIngredients-Asia Awards 2023.
July 10, 2023
Maintaining mental clarity and having a focused mind is crucial for productive life and overall well-being in today's fast world. While there are various
July 6, 2023
Diagnosed with lung cancer in the uk is expected to overtake men this year for the first time. and take a look at this, this rather striking image of the london eye, lit up in blue last night as part of celebrations to mark the 75th anniversary of the nhs. buildings lit up. that was yesterday evening. i always think when the london eye is lit up it is a sight to behold. it london eye is lit up it is a sight to behold-— london eye is lit up it is a sight to behold. ., , ., . to behold. it does ...
July 6, 2023
>> lecanemab is the first consistently effective disease modifying therapy for alzheimers. i think that qualifies it as a game changer. >> reporter: in all thymus patients, amyloid proteins form plaques in the brain which interrupt normal communication between nerve cells, leading to cognitive decline. lecanemab is an antibody that removes existing plaques and prevents new ones from forming. does this new drug actually delay the decline in cognitive function? >> it slows the declined by about 27...